What are the common side effects of Losartan (angiotensin II receptor antagonist) and their frequencies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Side Effects of Losartan

The most common side effects of losartan are upper respiratory infections (8%), dizziness (3%), nasal congestion (2%), and back pain (2%), with these occurring more frequently than with placebo according to FDA data. 1

Frequency of Common Side Effects

Losartan is generally well-tolerated with an overall incidence of adverse events similar to placebo. According to the FDA drug label, the following side effects occur in ≥2% of patients treated with losartan and more commonly than with placebo:

  • Upper respiratory infection: 8% (vs 7% with placebo)
  • Dizziness: 3% (vs 2% with placebo)
  • Nasal congestion: 2% (vs 1% with placebo)
  • Back pain: 2% (vs 1% with placebo) 1

Less Common Side Effects

The FDA label also reports these less common adverse reactions:

  • Blood and Lymphatic System: Anemia
  • Psychiatric: Depression
  • Nervous System: Somnolence, headache, sleep disorders, paresthesia, migraine
  • Ear and Labyrinth: Vertigo, tinnitus
  • Cardiac: Palpitations, syncope, atrial fibrillation, CVA
  • Respiratory: Dyspnea
  • Gastrointestinal: Abdominal pain, constipation, nausea, vomiting
  • Skin: Urticaria, pruritus, rash, photosensitivity
  • Musculoskeletal: Myalgia, arthralgia
  • Reproductive System: Impotence
  • General: Edema 1

Special Populations

Patients with Hypertension and Left Ventricular Hypertrophy

In the LIFE study, adverse reactions with losartan were similar to those reported for general hypertension patients. 1

Patients with Type 2 Diabetes and Nephropathy

In the RENAAL study, discontinuation rates due to side effects were similar between losartan and placebo (19% vs 24%). 1

Cough Comparison with ACE Inhibitors

One notable advantage of losartan over ACE inhibitors is the significantly lower incidence of cough:

  • In controlled studies of patients who had experienced ACE inhibitor-induced cough:
    • Losartan: 17-29% experienced cough
    • Lisinopril (ACE inhibitor): 62-69% experienced cough
    • Placebo/HCTZ: 25-35% experienced cough 1

This makes losartan a suitable alternative for patients who develop cough with ACE inhibitors.

Serious Side Effects to Monitor

While generally well-tolerated, patients should be monitored for:

  • Hypotension, especially in volume-depleted patients
  • Hyperkalemia (elevated potassium levels)
  • Worsening renal function in patients with pre-existing kidney problems
  • Allergic reactions including angioedema (rare but serious) 1

Pregnancy Considerations

Losartan is contraindicated in pregnancy as it can cause injury or death to the developing fetus, particularly when used in the second and third trimesters. 1

Clinical Implications

When prescribing losartan, clinicians should:

  1. Monitor blood pressure within 1-2 weeks after initiation or dose changes 2
  2. Monitor renal function and potassium levels, particularly in patients with pre-existing kidney disease 3
  3. Be aware that higher doses (up to 100 mg daily for hypertension or 150 mg daily for heart failure) may be needed for optimal outcomes 2
  4. Consider that losartan has a favorable drug interaction profile compared to many other antihypertensives 4

Losartan's generally favorable side effect profile makes it a good option for patients with hypertension, particularly those who cannot tolerate ACE inhibitors due to cough.

References

Guideline

Hypertension and Heart Failure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical pharmacokinetics of losartan.

Clinical pharmacokinetics, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.